Holen Sie sich die Stockscreener-App
102.34
0.04%
0.04
Handel nachbörslich:
102.20
-0.14
-0.14%
Exact Sciences Corp Aktie (EXAS) Neueste Nachrichten
Abbott Laboratories Resets Portfolio With Exact Sciences Cancer Diagnostics Deal - Yahoo Finance UK
Freedom Capital Markets upgrades Abbott Labs stock rating to Buy on Exact Sciences deal - Investing.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More - AOL.com
Exact Sciences Corp. (EXAS) Rose Following the Acquisition Announcement - Insider Monkey
EFG Asset Management North America Corp. Purchases 12,900 Shares of Exact Sciences Corporation $EXAS - MarketBeat
3 Reasons to Buy This Dividend King After Its Steep Sell-Off - The Motley Fool
Baillie Gifford & Co. Lowers Holdings in Exact Sciences Corporation $EXAS - MarketBeat
A Look At Exact Sciences (EXAS) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance
Lobbying Update: $420,000 of EXACT SCIENCES lobbying was just disclosed - Quiver Quantitative
Halper Sadeh Investigates Potential Securities Violations by Penumbra, Exact Sciences, DigitalBridge, and Flushing Financial - Intellectia AI
Mizuho downgrades Exact Sciences (EXAS) - MSN
Short Squeeze: Is Village Farms International Inc stock a good pick for beginnersJuly 2025 Selloffs & AI Enhanced Trading Signals - baoquankhu1.vn
Assessing Exact Sciences: Insights From 16 Financial Analysts - Benzinga
Exact Sciences Corp.: How a Diagnostics Powerhouse Is Rewriting the Playbook on Early Cancer Detecti - AD HOC NEWS
Exact Sciences (EXAS) Downgraded by Mizuho, Price Target Raised to $105 | EXAS Stock News - GuruFocus
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Exact Sciences (EXAS) Rose Following the Acquisition Announcement by Abbott - Yahoo Finance
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - 24/7 Wall St.
Mizuho downgrades Exact Sciences stock to Neutral on Abbott acquisition - Investing.com
Mizuho downgrades Exact Sciences stock to Neutral on Abbott acquisition By Investing.com - Investing.com Nigeria
Exact Sciences’ MCED Test Study: A Potential Game-Changer in Early Cancer Detection - MSN
Exact Sciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences CorporationEXAS - marketscreener.com
Why Abbott Laboratories (ABT) Story Is Shifting With Exact Sciences Deal Talk And Legal Wins - Yahoo Finance
Robeco Institutional Asset Management B.V. Lowers Stake in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Corporation (EXAS) Stock Analysis: Strong Revenue Growth Amid High Valuation - DirectorsTalk Interviews
Exact Sciences (EXAS) Valuation Check After Strong Multi Month Share Price Momentum - Yahoo Finance
Is Exact Sciences (EXAS) Still Attractive After An 81% One Year Share Price Surge - Yahoo Finance
Is Exact Sciences Corporation stock a safe haven assetInsider Selling & Real-Time Volume Trigger Notifications - ulpravda.ru
Peregrine Capital Management LLC Grows Position in Exact Sciences Corporation $EXAS - MarketBeat
Will Exact Sciences Corporation stock benefit from sector rotationGold Moves & Low Drawdown Investment Strategies - ulpravda.ru
How Exact Sciences Corporation stock reacts to job market dataMarket Trend Report & Free AI Powered Buy and Sell Recommendations - ulpravda.ru
How Exact Sciences Corporation stock reacts to bond yieldsJuly 2025 Rallies & Risk Controlled Daily Plans - ulpravda.ru
Can Exact Sciences Corporation (EXK) stock retain market dominanceJuly 2025 Trends & Safe Capital Growth Trade Ideas - ulpravda.ru
Abbott’s $105 Bid Put Exact Sciences Back In Play - Finimize
Assessing Exact Sciences (EXAS) Valuation After A Strong Momentum-Driven Share Price Run - simplywall.st
EXAS Stock Rating Downgraded to 'In-Line' by Evercore ISI Group - GuruFocus
Exact Sciences Corporation (EXAS) Stock Analysis: Unveiling Growth Potential In Cancer Diagnostics - DirectorsTalk Interviews
Abbott bets on cancer screening with $23 billion Exact Sciences deal - MSN
Pharma News: Can Exact Sciences Corporation EXK stock retain market dominanceVolume Spike & Free Fast Entry Momentum Trade Alerts - moha.gov.vn
1 High-Flying Stock on Our Watchlist and 2 We Question - Finviz
Top 2 Health Care Stocks That May Crash In Q1 - Benzinga
Cwm LLC Purchases 28,975 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Stock Is Going Wild: Is This Cancer-Test Giant a Hidden Gem or Total Trap? - AD HOC NEWS
19,260 Shares in Exact Sciences Corporation $EXAS Purchased by Strait & Sound Wealth Management LLC - MarketBeat
Exact Sciences Corp.: Turning DNA Into a Weapon Against Cancer - AD HOC NEWS
Smart Oncology: 5 Stocks Chasing the $317B Prize - The Globe and Mail
Alert from law firm on Exact Sciences-Abbott deal withdrawn - marketscreener.com
Exact Sciences Shareholders Unhappy With $105 Per Share Sale to Abbott Should Contact Julie ... - Bluefield Daily Telegraph
Should You Continue to Hold EXAS Stock in Your Portfolio Now? - WV News
Exact Sciences Corp.: How a Diagnostics Powerhouse Is Rewriting the Cancer Playbook - AD HOC NEWS
Exact Sciences Corp. Stock Tests Investor Patience as Diagnostics Story Enters a New Act - AD HOC NEWS
1.19%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):